Poly Medicure Ltd. (POLYMED) Share Price Rises 5.11% Today: What the Move Shows
- September 2, 2026
- Posted by: Harsh Piplani
- Category: News
Poly Medicure Ltd. Share Price rose to Rs 1,844.8 on 02 September 2026, up Rs 89.7 or 5.11% from the previous close of Rs 1,755.1. The stock opened at Rs 1,755, touched a day high of Rs 1,858 and a day low of Rs 1,740.6. Turnover stood at Rs 2.26 crore and market capitalisation at Rs 17,871.04 crore.
The supplied data confirms a sharp same-day move, but it does not identify a company-specific catalyst. That means the current discussion around Poly Medicure Ltd. Share Price is centered on price action, valuation and peer positioning rather than on a stated event.
Poly Medicure Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,844.8 |
| Previous Close | Rs 1,755.1 |
| Today's Move | Rs 89.7 (+5.11%) |
| Open | Rs 1,755 |
| High | Rs 1,858 |
| Low | Rs 1,740.6 |
| Turnover | Rs 2.26 crore |
| Market Capitalisation | Rs 17,871.04 crore |
| Market Cap Category | Mid Cap |
Poly Medicure Ltd. (POLYMED) rose to Rs 1,844.8 from the previous close of Rs 1,755.1, a move of Rs 89.7 or 5.11%. The stock opened at Rs 1,755, reached a high of Rs 1,858, recorded a low of Rs 1,740.6.
From the previous close of Rs 1,755.1, the stock added Rs 89.7 to trade at Rs 1,844.8, a gain of 5.11%. The session began at Rs 1,755, slipped to Rs 1,740.6 and then recovered strongly toward the upper end of the day’s range, with a high of Rs 1,858. On the supplied snapshot, that leaves the stock just Rs 13.2 below the day high and Rs 104.2 above the day low.
Turnover of Rs 2.26 crore shows the move came with measurable trading activity, though the data does not support any conclusion beyond the recorded price rise. For readers tracking Poly Medicure Ltd. Share Price Today, the key takeaway is straightforward: the stock moved from flat at the open versus the previous close to a solid intraday gain by the recorded timestamp of 02 September 2026 at 10:49:07 AM IST.
Poly Medicure Ltd. (POLYMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 17,871.04 crore |
| P/E Ratio | 56.46x |
| P/B Ratio | 5.59x |
| ROE | 10.94% |
| ROCE | 14.05% |
| EPS | Rs 31.09 |
| Book Value Per Share | Rs 313.97 |
| Dividend Yield | 0.2% |
Poly Medicure Ltd. (POLYMED) fundamental metrics show P/E 56.46x, P/B 5.59x, ROE 10.94%, ROCE 14.05%. These figures provide context only and are not a buy or sell signal.
Poly Medicure Ltd. has a market capitalisation of Rs 17871.04 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 56.46x, P/B at 5.59x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.94% and ROCE of 14.05%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 31.09, book value per share of Rs 313.97, dividend yield of 0.2%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 28.86x, median ROE of 14%, median ROCE of 16.41%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Medical Equipment/Supplies/Accessories |
| Benchmark Scope | same industry |
| Company P/E Ratio | 56.46x |
| Benchmark Median P/E | 28.86x |
| Benchmark Average P/E | 89.73x |
| Benchmark P/E Range | 7.55x to 1,051.05x |
| Company P/B Ratio | 5.59x |
| Benchmark Median P/B | 3.47x |
| Company ROE | 10.94% |
| Benchmark Median ROE | 14% |
| Company ROCE | 14.05% |
| Benchmark Median ROCE | 16.41% |
| Company Market Capitalisation | Rs 17,871.04 crore |
| Benchmark Median Market Cap | Rs 164.92 crore |
Poly Medicure Ltd. (POLYMED) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.
Poly Medicure Ltd. (POLYMED) has a P/E ratio of 56.46x, which is above the benchmark median of 28.86x, a difference of +95.63%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Poly Medicure Ltd. (POLYMED) has a ROE of 10.94%, which is below the benchmark median of 14%, a difference of -21.86%. Poly Medicure Ltd. (POLYMED) has a ROCE of 14.05%, which is below the benchmark median of 16.41%, a difference of -14.38%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| LENSKART SOLUTIONS LTD | LENSKART | 1,15,237.73 | 176.15 | 12.91 | 6.85 | 12.55 |
| Q-LINE BIOTECH LIMITED | QLINE | 1,389.31 | 24.58 | 6.47 | 13.94 | 19.19 |
| 3B Blackbio Dx Ltd. | 3BBLACKBIO | 1,241.18 | 23.53 | 4.67 | 19.41 | 26.03 |
| LAXMI DENTAL LIMITED | LAXMIDENTL | 1,075 | 34.2 | 4.18 | 21.4 | 24.97 |
| Osel Devices Ltd. | OSELDEVICE | 663.03 | 22.67 | 6.05 | 30.09 | 31.15 |
Poly Medicure Ltd. (POLYMED) has a P/E ratio of 56.46x compared with the displayed peer median of 24.58x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.94% compares with a peer median of 19.41% across the companies shown in the table. ROCE stood at 14.05% versus the displayed peer median of 24.97%, providing a capital-efficiency comparison. Poly Medicure Ltd. (POLYMED) has a market capitalisation of Rs 17,871.04 crore. Among the 5 peers shown, 1 have a larger market capitalisation.
Why Investors Are Watching Poly Medicure Ltd.
- The stock rose 5.11% to Rs 1,844.8, up Rs 89.7 in a single session.
- The intraday range of Rs 1,740.6 to Rs 1,858 shows a recovery from the low toward the high.
- Market capitalisation of Rs 17,871.04 crore is far above the industry median of Rs 164.92 crore.
- P/E 56.46 and P/B 5.59 are above industry medians of 28.86 and 3.47.
- ROE 10.94% and ROCE 14.05% trail the industry medians of 14% and 16.41% and several supplied peers.
About Poly Medicure Ltd.
Poly Medicure Ltd. is classified under Healthcare and the Medical Equipment/Supplies/Accessories industry. In this article, the company is being viewed through a same-industry lens rather than through a disclosed news catalyst. That is why the emphasis remains on size, valuation and profitability relative to comparable listed names.
Track Poly Medicure Ltd. Share Price on Univest
Use Poly Medicure Ltd. (POLYMED) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Use the Poly Medicure Ltd. (POLYMED) live share-price page, the top gainers screener and Univest market blogs to follow live price moves, sector context and related market coverage. For readers monitoring Poly Medicure Ltd. Share Price, these pages bring together price, market cap and fundamental snapshots in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Poly Medicure Ltd. Share Price rising today?
Ans. The supplied snapshot shows Poly Medicure Ltd. Share Price at Rs 1,844.8, up Rs 89.7 or 5.11% from the previous close of Rs 1,755.1. The data confirms the rise but does not provide a company-specific reason.
How does valuation compare with the industry?
Ans. The company trades at P/E 56.46 versus industry median 28.86 and average 89.73. Its P/B is 5.59 versus median 3.47 and average 4.01. So valuation is above median on both measures.
What do profitability metrics show?
Ans. ROE is 10.94% and ROCE is 14.05%. These are below the same-industry medians of 14% and 16.41% and below several of the named peers in the comparison set. ROE stands at 10.94%.
What is the company’s market capitalisation?
Ans. Market capitalisation is Rs 17,871.04 crore. That is above the same-industry median of Rs 164.92 crore and above the average of Rs 6,360.67 crore. The company operates in the Healthcare sector.
